Cargando…

A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells

SIMPLE SUMMARY: Dopamine receptor type 2 (DRD2) mediates antitumoral effects in different types of pituitary tumors with variable efficacy. DRD2′s functionally selective agonists are able to preferentially activate the canonical G-protein-mediated signaling arm or the β-arrestin 2 pathway, which hav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Muro, Genesio, Mangili, Federica, Esposito, Emanuela, Barbieri, Anna Maria, Catalano, Rosa, Treppiedi, Donatella, Marra, Giusy, Nozza, Emma, Lania, Andrea G. A., Ferrante, Emanuele, Locatelli, Marco, Arosio, Maura, Peverelli, Erika, Mantovani, Giovanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296728/ https://www.ncbi.nlm.nih.gov/pubmed/37370829 http://dx.doi.org/10.3390/cancers15123218

Ejemplares similares

PMON171 DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Pituitary Neuroendocrine Tumoral Cells
por: Mangili, Federica, et al.
Publicado: (2022)

DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells
por: Mangili, Federica, et al.
Publicado: (2022)

TMPRSS2 Expression and Activity Modulation by Sex-Related Hormones in Lung Calu-3 Cells: Impact on Gender-Specific SARS-CoV-2 Infection
por: Treppiedi, Donatella, et al.
Publicado: (2022)

SAT-312 Beta-Arrestin 2 Is Required for Dopamine Receptor Type 2 Inhibitory Effects on Akt Phosphorylation and Cell Proliferation in Pituitary Tumors
por: Mangili, Federica, et al.
Publicado: (2020)

A Novel Mechanism Regulating Dopamine Receptor Type 2 Signal Transduction in Pituitary Tumoral Cells: The Role of cAMP/PKA-Induced Filamin A Phosphorylation
por: Mangili, Federica, et al.
Publicado: (2021)

Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST(2) and SST(5) homo- and hetero-dimer formation
por: Treppiedi, Donatella, et al.
Publicado: (2022)

P720R USP8 Mutation Is Associated with a Better Responsiveness to Pasireotide in ACTH-Secreting PitNETs
por: Treppiedi, Donatella, et al.
Publicado: (2022)

Genetic Profiling of a Cohort of Italian Patients with ACTH-Secreting Pituitary Tumors and Characterization of a Novel USP8 Gene Variant
por: Treppiedi, Donatella, et al.
Publicado: (2021)

MON-465 SST2 Trafficking Through The Cytoskeleton: Role Of Scaffolding Proteins Filamin A And β-arrestin 2
por: Treppiedi, Donatella, et al.
Publicado: (2019)

SAT-566 Cofilin Is a Mediator of RET-Promoted Medullary Thyroid Carcinoma Cell Migration, Invasion and Proliferation
por: Peverelli, Erika, et al.
Publicado: (2019)

Stem Cells in Pituitary Tumors: Experimental Evidence Supporting Their Existence and Their Role in Tumor Clinical Behavior
por: Mantovani, Giovanna, et al.
Publicado: (2019)

SUN-213 The Role of Filamin A (FLNA) in the Regulation of Insulin-Like Growth Factor System in Adrenocortical Carcinomas
por: Peverelli, Erika, et al.
Publicado: (2020)

Cabergoline Withdrawal Before and After Menopause: Outcomes in Microprolactinomas
por: Indirli, Rita, et al.
Publicado: (2019)

Role of filamin A in the pathogenesis of neuroendocrine tumors and adrenal cancer
por: Treppiedi, Donatella, et al.
Publicado: (2022)

SAT-272 Pituitary Macroadenoma Co-Secreting TSH and PRL Responsive to Cabergoline
por: Tirumalasetty, Saritha, et al.
Publicado: (2020)

SAT-475 PRL Secreting Macroadenoma and Development CSF Leak Secondary to Cabergoline Use
por: Ulrich, Jenna, et al.
Publicado: (2019)

β-Arrestin2-biased Drd2 agonist UNC9995 alleviates astrocyte inflammatory injury via interaction between β-arrestin2 and STAT3 in mouse model of depression
por: Liu, Yang, et al.
Publicado: (2022)

α-Synuclein disrupts the anti-inflammatory role of Drd2 via interfering β-arrestin2-TAB1 interaction in astrocytes
por: Du, Ren-Hong, et al.
Publicado: (2018)

Dopamine and Somatostatin Analogues Resistance of Pituitary Tumors: Focus on Cytoskeleton Involvement
por: Peverelli, Erika, et al.
Publicado: (2015)

Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer
por: Radke, I, et al.
Publicado: (2006)

Association Between DRD2 and DRD4 Polymorphisms and Eating Disorders in an Italian Population
por: Ceccarini, Maria Rachele, et al.
Publicado: (2022)

Sequence analysis of Drd2, Drd4, and Dat1 in SHR and WKY rat strains
por: Mill, Jonathan, et al.
Publicado: (2005)

Cannabinoid, melanocortin and opioid receptor expression on DRD1 and DRD2 subpopulations in rat striatum
por: Oude Ophuis, Ralph J. A., et al.
Publicado: (2014)

Unravelling the interaction between the DRD2 and DRD4 genes, personality traits and concussion risk
por: Abrahams, Shameemah, et al.
Publicado: (2019)

Molecular mechanisms involved in somatostatin receptor regulation in corticotroph tumors: the role of cytoskeleton and USP8 mutations
por: Peverelli, Erika, et al.
Publicado: (2022)

FRI294 The Dopamine Agonist Cabergoline Targets Multiple Pathways To Inhibit PRL Secretion And Increases Stromal Fibrosis Via The Serotonin Receptor 5HTR1F
por: Zhang, Dongyun, et al.
Publicado: (2023)

The Association of DRD2 with Insight Problem Solving
por: Zhang, Shun, et al.
Publicado: (2016)

Expanding the Spectrum of Dopa-Responsive Dystonia (DRD) and Proposal for New Definition: DRD, DRD-plus, and DRD Look-alike
por: Lee, Woong-Woo, et al.
Publicado: (2018)

No association of DRD2, DRD3, and tyrosine hydroxylase gene polymorphisms with personality traits in the Japanese population
por: Hibino, Hiroyuki, et al.
Publicado: (2006)

Prevalence of polymorphisms in the ANKK1, DRD2, DRD3 genes and metabolic syndrome in refractory schizophrenia
por: Pinto, Jeizziani Aparecida Ferreira, et al.
Publicado: (2018)

Potentiation of latent inhibition by haloperidol and clozapine is attenuated in Dopamine D2 receptor (Drd-2)-deficient mice: Do antipsychotics influence learning to ignore irrelevant stimuli via both Drd-2 and non-Drd-2 mechanisms?
por: O’Callaghan, Matthew J, et al.
Publicado: (2014)

PRL-2 phosphatase is required for vascular morphogenesis and angiogenic signaling
por: Poulet, Mathilde, et al.
Publicado: (2020)

DRD2, DRD3, and HTR2A Single-Nucleotide Polymorphisms Involvement in High Treatment Resistance to Atypical Antipsychotic Drugs
por: Del Casale, Antonio, et al.
Publicado: (2023)

DRD2 and DRD4 genes related to cognitive deficits in HIV-infected adults who abuse alcohol
por: Villalba, Karina, et al.
Publicado: (2015)

Dopamine DRD2 and DRD3 Polymorphisms Involvement in Nicotine Dependence in Patients with Treatment-Resistant Mental Disorders
por: del Casale, Antonio, et al.
Publicado: (2022)

PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
por: Thura, Min, et al.
Publicado: (2019)

Olfactory regulation by dopamine and DRD2 receptor in the nose
por: Zhou, Hai-Qian, et al.
Publicado: (2022)

Impact of the DRD2 Polymorphisms on the Effectiveness of the Training Program
por: Świtała, Katarzyna, et al.
Publicado: (2022)

NEK2 regulates cellular proliferation and cabergoline sensitivity in pituitary adenomas
por: Jian, Fangfang, et al.
Publicado: (2021)

Defining the roles of arrestin2 and arrestin3 in vasoconstrictor receptor desensitization in hypertension
por: Willets, Jonathon M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4eb5onkb80i9496o2g815vp1o6